These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26892289)

  • 1. Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders.
    Forlenza OV; Aprahamian I; de Paula VJ; Hajek T
    Curr Alzheimer Res; 2016; 13(8):879-86. PubMed ID: 26892289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease.
    Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV
    Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is lithium a neuroprotective agent?
    Vo TM; Perry P; Ellerby M; Bohnert K
    Ann Clin Psychiatry; 2015 Feb; 27(1):49-54. PubMed ID: 25696782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of lithium: what are the implications in humans with neurodegenerative disorders?
    Morlet É; Hozer F; Costemale-Lacoste JF
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Mar; 16(1):78-86. PubMed ID: 29400298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Perspectives of Lithium's Neuroprotective Effect.
    Rybakowski JK; Suwalska A; Hajek T
    Pharmacopsychiatry; 2018 Sep; 51(5):194-199. PubMed ID: 29270949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial (Thematic Issue: Neuroprotective Effects of Li - It is Elementary).
    Hajek T; Young A
    Curr Alzheimer Res; 2016; 13(8):846-7. PubMed ID: 27040138
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium: a novel treatment for Alzheimer's disease?
    Zhong J; Lee WH
    Expert Opin Drug Saf; 2007 Jul; 6(4):375-83. PubMed ID: 17688381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Studies of Association Between Lithium and Risk of Neurodegenerative Disorders.
    Donix M; Bauer M
    Curr Alzheimer Res; 2016; 13(8):873-8. PubMed ID: 26892288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?
    Chuang DM; Manji HK
    Biol Psychiatry; 2007 Jul; 62(1):4-6. PubMed ID: 17572175
    [No Abstract]   [Full Text] [Related]  

  • 12. Lithium Therapy's Potential to Lower Dementia Risk and the Prevalence of Alzheimer's Disease: A Meta-Analysis.
    Lu Q; Lv H; Liu X; Zang L; Zhang Y; Meng Q
    Eur Neurol; 2024; 87(2):93-104. PubMed ID: 38657568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update - Lithium in the Long-Term Treatment of Bipolar Disorders].
    Petzold J; Bauer M; Severus E
    Fortschr Neurol Psychiatr; 2018 Dec; 86(12):745-753. PubMed ID: 30419584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Putative Use of Lithium in Alzheimer's Disease.
    Morris G; Berk M
    Curr Alzheimer Res; 2016; 13(8):853-61. PubMed ID: 26892287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.
    Forlenza OV; Diniz BS; Radanovic M; Santos FS; Talib LL; Gattaz WF
    Br J Psychiatry; 2011 May; 198(5):351-6. PubMed ID: 21525519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.
    Lauterbach EC; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):242-60. PubMed ID: 21948886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium.
    Fornai F; Longone P; Ferrucci M; Lenzi P; Isidoro C; Ruggieri S; Paparelli A
    Autophagy; 2008 May; 4(4):527-30. PubMed ID: 18367867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.
    Mueller SG; Schuff N; Weiner MW
    NMR Biomed; 2006 Oct; 19(6):655-68. PubMed ID: 16986115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.